Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Khoury RM, Camacho-Lobato L, Katz PO, Mohiuddin MA, Castell DO
The prescription medication was formulated by Novo Nordisk and first received FDA approval for use as a type 2 diabetes treatment in December 5, 2017, resulting in the introduction of Ozempic as a once-weekly injectable GLP-1 receptor agonist designed to regulate blood sugar by enhancing insulin production
Pharmaceutical Benefits Scheme (PBS)
This is due, at least in part, to recent outcome trial data supporting the use of select GLP-1 RAs and SGLT-2 inhibitors to mitigate cardiovascular and renal risks in at-risk patients
US$ 25.07
US$ 27.67
US$ 28.47
US$ 27.75
